Touchlight extends funding round to boost...UK-based DNA synthesis specialist Touchlight Ltd has extended a funding round to a current aggregate total of US $125m. more ➔
Meatable teams up with Royal DSMRoyal DSM is backing Meatable, the cultivated meat start-up, in order to develop growth media for cultivated meat. more ➔
US$21m for microbiome therapiesEnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline. more ➔
Swiss Biotech Day shows great biopharma am...The Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel. more ➔
Owlstone: US$59m for breath biopsy develop...Owlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the companys breath biopsy tests. more ➔
EU ends litigation with AstraZenecaThe EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule. more ➔
EuropaBio lobbies for better Orphan Drug r...EuropaBio has responded to the European Commissions public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations. more ➔
AcquisitionVectivBio expands rare disease pipelineSwiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases. more ➔
Call for pull incentives to get startedWith new backing from large pharma, rising investors interest, and new incubators on stage, the AMR community is now urging policy makers worldwide to bring pull incentives into reality. more ➔
ADC Therapeutics: US$325m for ADC royaltie...ADC Therapeutics is set to receive up to US$325m for a royalty share in its antibody drug conjugates Zynlonta and Cami. more ➔
